Market World Pharmacovigilance Market Applications | Page 2

Based on the type of method, HER mining, spontaneous reporting, cohort event monitoring, intensified ADR
reporting, targeted spontaneous reporting, and others could classify pharmacovigilance market in the forecast
period. Spontaneous report sector accounted for the significant market share of pharmacovigilance and is
estimated to continue its dominance in the years to come. Also, the cohort event monitoring sector is estimated
to grow at the fastest pace in the years to come.
The market may be categorized based on end-users like industrial, hospitals, research organizations, and others
that could be explored in the forecast period. The hospitals sector accounted for the substantial market share
of pharmacovigilance and is estimated to lead the overall market in the years to come. Also, the research
organization sector is estimated to grow at the fastest pace in the years to come.
Globally, North America accounted for the substantial share of pharmacovigilance industry and is estimated to
lead the overall market in the years to come. The reason behind the overall market growth could be the
presence of key manufacturers in the region and the high investment in the development of new drugs. The
United States and Canada are the major consumers of pharmacovigilance in the years to come.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/pharmacovigilance-pv-market
Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the
second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest
CAGR in the forecast period. The developing countries like India and China are the major consumers of
pharmacovigilance in this region.
The key players of pharmacovigilance (PV) industry are United BioSource Corporation, Accenture, Wipro Ltd.,
Clinquest Group B.V., BioClinica, Cognizant, PAREXEL International Corporation, and Laboratory Corporation of
America Holdings, TAKE Solutions Ltd., IBM Corporation, Foresight Group International AG, ArisGlobal, and
iMEDGlobal. These players are concentrating on inorganic growth to sustain themselves amidst fierce
competition.
Market Segment:
Pharmacovigilance Clinical Trial Phase Outlook (Revenue, USD Million, 2014 - 2025)
• Pre-clinical
• Phase I
• Phase II